Skip to content
healthcare.dev

GRANIX

NDC 63459-920, tbo-filgrastim, injection, solution, from Cephalon, LLC.

Product NDC
63459-920
Status
Listed
Labeler
Cephalon, LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125294
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63459-920 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FILGRASTIM480 ug/1.6mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/df918ec2-0907-443f-a52a-b72866959644
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63459-920

Use it

Look up 63459-920 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63459-920 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63459-920. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.